A study yet to be peer-reviewed has assessed the evidence on treating COVID-19 with antibody infusions—particularly monoclonal antibodies. It has found that in the early days of the pandemic doses were too high—but things are different with Omicron and its variants, because the antibodies target different sections of ... Show More
Aug 2023
Monoclonal Antibodies Targeting Amyloid for Alzheimer Disease
In this interview, dementia expert Gil D. Rabinovici, MD, discusses monoclonal antibodies that target beta-amyloid–-including a recent phase 3 trial of donanemab published in JAMA-–and reviews considerations for their use in patients with Alzheimer disease. Related Content: Amylo ... Show More
28m 48s
Apr 2023
S2 Episode 2: When Viral Pandemics Collide: Vaccinating, Boosting and Caring for Patients Diagnosed With HIV During the Time of COVID
Drs Michael S. Saag and Monica Gandhi discuss COVID-19 and the impact this pandemic has had on patients diagnosed with HIV, including vaccines, boosters, and patients who are older or have chronic comorbid conditions. Relevant disclosures can be found with the episode show notes ... Show More
24m 7s
Aug 2021
TMHS 508: Covid-19 Vaccine Efficacy & Antibody Dependent Enhancement
We know that as viruses spread, their genetic makeup can change, meaning the virus can mutate into variants. In a scenario with mass vaccination, a mechanism called antibody-dependent enhancement can occur. This means that instead of stopping an infection, antibodies actually can ... Show More
1h 7m
Jul 2022
Shmuel Shoham, MD - Do You Know How to Use COVID-19 Monoclonal Antibodies as Pre-Exposure Prophylaxis for Your Post-Transplant Patients? Test Your Knowledge
Go online to PeerView.com/EWZ860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Solid organ transplant recipients may be at increased risk for COVID-19 because they are immunosuppressed and less likely to mount effective immune ... Show More
48m 20s